Sono-Flexocatalytic Tumor Suppression Enabled by SrTiO₃ Nanoflexocatalysts

科学分野:

• Biomaterials Science
• Nanotechnology
• Oncology

背景:

• Piezocatalytic tumor therapy shows promise but requires non-centrosymmetric catalysts.
• Centrosymmetric materials, like strontium titanate (SrTiO3), are typically unsuitable for such applications.
• A novel approach is needed to utilize readily available centrosymmetric materials for non-invasive tumor treatment.

研究 の 目的:

• To develop a novel sono-flexocatalytic therapy (SFT) strategy using centrosymmetric SrTiO3 nanocatalysts.
• To overcome the material limitations of traditional piezocatalytic tumor therapy.
• To demonstrate the efficacy of SFT in suppressing tumor growth through ultrasound-induced flexoelectricity.

主な方法:

• Utilized centrosymmetric strontium titanate (SrTiO3) nanocatalysts.
• Applied ultrasound irradiation to induce strain gradients and flexoelectric polarization in SrTiO3.
• Investigated the generation of reactive oxygen species (ROS) and their cytotoxic effects on tumor cells.
• Validated the SFT strategy through in vitro and in vivo tumor models.
• Employed theoretical simulations to elucidate the sono-flexocatalytic mechanism.

主要な成果:

• Ultrasound irradiation of SrTiO3 generated significant flexoelectric polarization and charge separation.
• This process led to the production of abundant cytotoxic ROS (hydroxyl radicals, superoxide anions) within tumor cells.
• The induced oxidative stress resulted in mitochondrial dysfunction and apoptosis, effectively suppressing tumor growth.
• In vitro and in vivo studies confirmed the therapeutic efficacy of SFT.
• Theoretical simulations clarified the strain-gradient dependent flexocatalytic mechanism.

結論:

• Sono-flexocatalytic therapy (SFT) offers a new non-invasive treatment modality for tumors using centrosymmetric SrTiO3 nanocatalysts.
• Ultrasound-triggered flexoelectricity in SrTiO3 effectively generates ROS for cancer therapy.
• This work expands the applicability of centrosymmetric biomaterials in sonocatalytic treatments and establishes a new paradigm for pancatalytic medicine.